Bernd Montag, Ph.D., has been CEO of Siemens Healthineers since February 2015. As of March 2018, the company is listed on the Frankfurt Stock Exchange as Siemens Healthineers AG (SHL). In September 2021, Siemens Healthineers joined the DAX, Germany’s most important stock market index.

Bernd Montag joined Siemens in 1995. He held positions in corporate quality management and sales in the hearing aid business before moving to the imaging systems unit in 1999, where he served as a product manager for computed tomography and as the head of marketing for the magnetic resonance business. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the imaging and therapy division, which combined the overall business of diagnostic imaging and image-guided therapies. 

Bernd Montag completed his studies in Physics at the Friedrich-Alexander-University, Erlangen-Nuremberg, and earned a Ph.D. in theoretical multi-particle physics. He was born in Munich, Germany, in 1969.

Dr. Bernd Montag

Dr. Bernd Montag

World Medical Innovation Forum
Sep 22 - 23, 2026
Boston, USA
Presented by Mass General Brigham in partnership with Bank of America, the World Medical Innovation Forum convenes clinicians and industry working together to advance patient benefitting technologies. It aims to provide a platform to explore solutions to the medical, operational, and economic challenges, ensuring that patients, providers, and healthcare organizations benefit as soon as possible. CEO Dr. Bernd Montag will participate and represent Siemens Healthineers under the conference’s theme “Innovation at speed and scale”.

ASTRO 2026
Sep 26 - 30, 2026
Boston, USA
ASTRO Annual Meeting is the flagship conference of the American Society for Radiation Oncology (ASTRO) and one of the world's leading events in radiation oncology and cancer care. It brings together radiation oncologists, medical physicists, researchers, healthcare providers, and industry leaders to discuss the latest advances in cancer treatment, clinical research, imaging, AI, and radiation therapy technologies. The meeting serves as a key platform for presenting groundbreaking scientific data, clinical trial results, and innovations that shape the future of oncology and patient care. CEO Dr. Bernd Montag will represent Siemens Healthineers at this year’s event.
Hauptstadtkongress 2026
Jun 23 - 25, 2026
Berlin, Germany
The Hauptstadtkongress is one of the most important congresses for decision-makers in the German healthcare sector. CEO Dr. Bernd Montag will attend a pre-event of the Hauptstadtkongress on June 22, 2026 and deliver the opening remarks for a panel on “The EU Safe Hearts Plan - Future-oriented approach to cardiovascular care” and will then be joined in the panel by: Simone Borchardt, health policy spokesperson of the CDU/CSU parliamentary group in the German Bundestag and spokesperson of the Health Committee, Prof. Dr. Stefan Blankenberg, President of the German Cardiac Society (DGK), Medical Director and Head of Clinic at the University Heart Center (UHZ) of the University Medical Center Hamburg-Eppendorf, and Prof. Dr. Ingo Hilgendorf, Director of the Department of Cardiology, Angiology and Intensive Care Medicine at the German Heart Center of the Charité.

Day of German Industry 2026
Jun 22 - 23, 2026, 11:15 am
Berlin, Germany
CEO Dr. Bernd Montag will participate in this year’s edition of the Federation of German Industries’ Day of Industry and a panel round with Dorothee Bär, Federal Minister of Research, Technology and Space, Jochen Hanebeck, CEO Infineon, and Eva Baumann, CEO CHT Group on June 23, from 11:15 pm to 12:00 pm.